Opioid drug conversion guidelines vary, conflict, study says

05/14/2013 | MedPage Today (free registration)

Guidelines for opioid drug conversion vary and sometimes conflict, and are based on single-dose studies that lack long-term data, according to a Purdue Pharma study presented at a meeting of the American Pain Society. The biggest variation was found in recommendations for hydromorphone and oxycodone. Dr. John Peppin of the Palliative Care Center in Lexington, Ky., agreed there is a problem, and physicians are aware of it.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA